Home » Newsletters » BioWorld Asia

BioWorld Asia

June 3, 1998

View Archived Issues

Canadian Start-Ups Increase With Surge In Venture Capital

Exiqon Spins Off Firm For Drugs That Mimic Nucleic Acids

Australia Earmarking A$20M To Boost Biotech Industry

EU Renews Efforts To Adopt Orphan Drug Regulations

Karo Bio Extends Alliance With UC Collaborators

Former Pharma Execs Bringing European Biotech To Japan

Progen Shares Surge, Retreat As Cancer Drug Enters Phase I

Inex Mouse Data Promising On Cancer Gene Therapy

Interferon Gene Therapy Beats HIV In Lab Studies

EU Explains 'Exceptional' Approval For Ares' Rebif

Other News to Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...